Singapore markets closed

Kronos Bio, Inc. (KRON)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.3000+0.0600 (+4.84%)
At close: 04:00PM EDT
1.3400 +0.04 (+3.08%)
After hours: 07:14PM EDT
Full screen
Loading interactive chart…
  • Zacks

    Kronos Bio (KRON) Upgraded to Buy: What Does It Mean for the Stock?

    Kronos Bio (KRON) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • GlobeNewswire

    Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results

    Phase 1/2 study of KB-0742 is on track to clear 80mg four-days-on, three-days-off schedule in the third quarter of 2024; topline data from expansion cohort at this schedule expected in the first half of 2025 IND-enabling studies for KB-9558 expected to complete in 2024 with first-in-human study anticipated to commence in the first half of 2025 $175.0 million in cash, cash equivalents and investments as of December 31, 2023, providing expected cash runway into the second half of 2026 SAN MATEO, C

  • GlobeNewswire

    Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway

    Company to assess KB-0742 at planned new dose schedule in ongoing phase 1/2 study; topline data from expansion cohort at new dose schedule expected in the first half of 2025 IND-enabling studies for KB-9558 expected to complete in 2024 with first-in-human study anticipated to commence in 2025 Restructuring plan extends anticipated cash runway into the second half of 2026 Company to continue to focus discovery efforts on maturing projects and Genentech collaboration activities SAN MATEO, Calif.,